Part 2: Augmented Renal Clearance and the Impact on Antimicrobial Therapy
Date & Time:
Tuesday, February 26, 2019
6:00pm - 6:30pm Registration and Dinner
6:30pm - 7:15pm Part 1 Presentation (no CPE)
7:15pm - 7:30pm Break
7:30pm - 8:30pm Part 2 Presentation (CPE)
Location:
Parkers' Restaurant & BarPresented By:
Part 1: Clinical Considerations in Immune Globulin Treatment
Desi Kotis, PharmD
Northwestern Memorial Hospital
Chicago, IL
Part 1 is not available for CPE credit. This program is provided by Takeda Pharmaceuticals America, Inc. This is a promotional education presentation; it will not be certified for continuing medical education credit.
In accordance with the PhRMA Code on interactions with Healthcare Professionals, attendance at this educational program is limited to healthcare professionals. As such, attendance by guests or spouses is not permitted.
By accepting any food and/or refreshments at this program, you represent that neither your employer nor the particular state(s) in which you are licensed impose restrictions that preclude you from accepting these items. This invitation is non-transferrable.
Part 2: Augmented Renal Clearance and the Impact on Antimicrobial Therapy
Craig Cooper, BS, PharmD, BCCCP, BCPS
Assistant Professor of Clinical Sciences
Roosevelt University College of Pharmacy
Schaumburg, IL
Northwestern Memorial Hospital
Chicago, IL
Part 2 is accredited for pharmacists | 1.0 contact hour (0.1 CEU)
This is an independent program provided by ICHP.
Registration:
Register online below. Registration deadline is Friday, February 22, 2019 at 9:00 am.
This program is free to ICHP members. However, those who do not attend and do not cancel at least 48 hours prior to the program will be charged $50 to cover expenses. Pre-registration is required. Please bring a copy of your email registration confirmation with you to the meeting.
Seating is limited to the first 50 people. Student seating will limited to the first 10 students.
Learning Objectives for Pharmacists:
1. List the properties of hydrophilic antibiotics which predispose them to augmented renal clearance.
2. Recognize the importance of beta-lactam antibiotics in augmented renal clearance dosing.
Accreditation:
The Illinois Council of Health System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 contact hour (0.1 CEU) of continuing pharmacy education credit. ACPE Universal Activity Number 0121-0000-19-020-L01-P. Type of Activity: Knowledge-based
Attendees must complete a program evaluation online and may immediately print their statements of continuing pharmacy education credit at
www.CESally.com.
Target Audience: This knowledge-based activity was developed for Health-System Pharmacists.
Faculty Disclosure: It is the policy of ICHP to ensure balance, independence, objectivity, and scientific rigor in all of its education programs. In accordance with this policy, faculty must disclose to the participants any significant relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of these continuing pharmacy education programs. Any resident or fellow presentation is reviewed by a content specialist preceptor. These disclosures will be available at the program.
CPE Monitor: When registering for this program, you will be asked to provide your NABP eProfile ID# and Birthday (MMDD) when registering for this meeting. This information is required by any participants seeking CPE credit.
Visit www.ichpnet.org/cpemonitor/ for information about CPE Monitor and how to obtain your NABP ID.
PTCB requires CPhTs to submit 20 hours of pharmacy technician-specific (‘T-specific’) continuing pharmacy education (CPE) to qualify for recertification. Please advise all pharmacy technicians at your site of this change. As an ACPE accredited provider, ICHP will continue to include Technician specific programming in most if not all of our CPE programming.
